Article Information
History
- May 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Johannes O. Ferstad, BA1,
- Jacqueline J. Vallon, MS1,
- Daniel Jun, MS1,
- Angela Gu, MS2,
- Anastasiya Vitko, BS2,
- Dianelys P. Morales, MS1,
- Jeannine Leverenz, RN, CDE3,
- Ming Yeh Lee, MD, PhD3,
- Brianna Leverenz, BS3,
- Christos Vasilakis, PhD4,
- Esli Osmanlliu, MD3,5,
- Priya Prahalad, MD, PhD3,6,
- David M Maahs, MD, PhD3,6,7,
- Ramesh Johari, PhD1,6,* and
- David Scheinker, PhD1,3,8,*,#
- 1Department of Management Science and Engineering, Stanford University School of Engineering, Stanford, California, USA
- 2Department of Computer Science, Stanford University School of Engineering, Stanford, California, USA
- 3Division of Pediatric Endocrinology, Stanford University School of Medicine, Stanford, California, USA
- 4Centre for Healthcare Innovation and Improvement (CHI2), School of Management, University of Bath, Bath, UK
- 5Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Centre, Montreal, Canada
- 6Stanford Diabetes Research Center, Stanford, California, USA
- 7Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
- 8Clinical Excellence Research Center, Stanford University School of Medicine, Stanford, California, USA
- ↵# Corresponding author; email: dscheink{at}stanford.edu
AUTHORSHIP CONTRIBUTIONS: J.F and J.V performed the data analyses.
J.F, D.J, and A.G. developed the clinic tools.
J.F, D.J., A.G., A.V., D.M., J.L., M.L., C.V., E.O., P.P., D.M., R.J., and D.S. contributed to the design of the clinic tools and patient review criteria.
J.F. D.J., J.L., B.L., P.P. deployed the clinic tools and tracked patient and provider outcomes. J.F., M.L., E.O., P.P., D.M., R.J., and D.S. wrote the paper.
Posted May 08, 2021.
Population-level management of Type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health
